Effect of Meshashrungi Patra vati and Ajashrungi Patra vati in management of Type 2 Diabetes mellitus-A Randomised, Single blind, Clinical Study
DOI:
https://doi.org/10.47552/ijam.v15i2.5014Keywords:
Meshashrungi, Ajashrungi, Madhumeha, Type II Diabetes mellitus, Single blind studyAbstract
India is known as the Diabetic capital of the world due to the increasing Diabetic population. Diabetes is increasing day by day because of lifestyle changes. As per the WHO statistics around 2 million deaths occur each year because of diabetes. Hence there is a serious concern to find an effective and safe medicine for the treatment of diabetes. Many herbal drugs have been researched and found to be effective in controlling the diabetes. One of such herbs is Gymnema sylvestre (Retz.) R.Br. ex Sm. (GS). It is equated with Meshashrungi, mentioned in the Ayurvedic texts. Ajashrungi (Pergularia daemia (Forssk.) Chiov.) (PD) is also taken as a substitute for Meshashrungi. So, to find out the efficacy of both the drugs in the management of diabetes, the present work is taken up. It was a Prospective, Randomised, Single blind, Comparative Clinical Study. A total of 40 subjects were randomised into two groups with 20 subjects each. Group A were administered Meshashrungi patra vati and Group B were administered Ajashrungi patra vati for a period of 60 days with a follow up for every 15 days. Assessment was done based on changes seen in subjective and objective Parameters. Significant changes were observed in both the groups before and after the treatment, but when compared between the groups there was no significant difference. This indicates that both the drugs are equally efficacious in the management of diabetes mellitus. Hence, both the drugs can be used as substitutes for the management of diabetes mellitus.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.